雅化集團(002497.SZ):擬申請廣期所碳酸鋰指定交割廠庫
格隆匯1月18日丨雅化集團(002497.SZ)在接待機構投資者調研時表示,自廣州期貨交易所碳酸鋰期貨上市以來,公司一直積極關注,也成立了專門的期貨團隊進行研究。為進一步對沖現貨交易風險,公司擬申請廣期所碳酸鋰指定交割廠庫。申請碳酸鋰期貨交割廠庫後,公司可以根據訂單隨時採購,降低原材料存貨,在節省成本和制定採購計劃方面具有重要意義。同時有利於公司將現貨市場、期貨市場、交割廠庫三者有機結合,進一步增強公司的抗風險能力和市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.